Showing results (1-10 of 834) with videos related to
Sort By:
Pageof 84
Bulletin Du Cancer|January 24, 2007
[Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?]Julien Grenier, Jean-Charles SoriaBulletin Du Cancer|June 4, 2013
[Discrepancies between primary tumor and metastasis: impact on personalized medicine]Stéphane Vignot, Jean-Charles SoriaClinical Lung Cancer|March 5, 2010
The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancerCorey Langer, Jean-Charles SoriaJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Lung cancer in HIV-positive patientsSuchita Pakkala, Suresh S RamalingamCurrent Opinion in Oncology|January 26, 2016
Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectivesSuchita Pakkala, Suresh S RamalingamClinical Lung Cancer|April 14, 2009
Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapySuchita Pakkala, Suresh S RamalingamHematology/Oncology Clinics of North America|December 4, 2016
Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment ParadigmSuchita Pakkala, Suresh S RamalingamFrontiers in Oncology|December 24, 2025
Rapidly evolving therapeutic advances for classical EGFR-mutant NSCLCKelsey Pan, Suresh S RamalingamJCI Insight|August 10, 2018
Personalized therapy for lung cancer: striking a moving targetSuchita Pakkala, Suresh S RamalingamCurrent Opinion in Oncology|December 17, 2009
Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hopeSuresh S Ramalingam, Chandra P BelaniPageof 84